BerlinBioCube (Haus D95), 13125 Berlin
enquiries@checkimmune.com

Added-value for your 
clinical development

Our Services

Do you want to accelerate attainment of approval for new, innovative drug candidates and minimize the development risks?

CheckImmune is an innovative service company offering the full biomarker package, from consulting and laboratory services to scientific and medical data interpretation, with a focus on immunology.

Selection/validation of drug lead candidates

Application of a broad panel of customized and off-the-shelf biomarker tests using cutting-edge technologies for lead candidate selection.

Phase 0 studies

Proof-of-concept studies on biosamples from target patient populations (phase 0) to confirm selected biomarker test portfolios for following therapy monitoring.

Therapy monitoring

Therapy monitoring in clinical trials to check safety, PD/PK, patient stratfication with a wide range of validated assays as well as newly developed customized methods.

Data analysis and scientific & medical interpretation

CheckImmune is backed by a world-renowned team of experts with years of academic and commercial experience in the field of biomarkers.

About us

CheckImmune is a spin-off company of Charité Universitätsmedizin Berlin with strong links to academic state-of-the art research. CheckImmune is providing biomarker studies with focus on novel immunotherapeutics (small molecules, biologics, Advanced Therapy Medicinal Products – ATMPs) and immunological challenges in other medical areas. CheckImmune is accredited according to ISO 17025 and 15189 and fulfills the requirements of GCLP (Good Clinical Laboratory Practice).

We are a team of well recognized experts for biomarker analyses and data interpretation.

With a track record of more than 60 industry-sponsored trials and 60,000 samples we have earned an excellent international reputation.

 

Would you like to talk to us?

Are you interested in working with us?

Start your career